Skip to main content
SpringerLink
Log in

Enigmas, priorities and opportunities in cancer epidemiology

  • ESSAY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Le Fanu J. The rise and fall of modern medicine. New York: Carroll & Graf; 2000.

    Google Scholar 

  2. Adami HO. Epidemiology and the elusive Nobel Prize. Epidemiology. 2009;20:635–7.

    Article  PubMed  Google Scholar 

  3. Edgren G, Liang L, Adami HO, Chang ET. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27(3):187–96. doi:10.1007/s10654-011-9647-5.

    Article  PubMed  Google Scholar 

  4. Abnet C, Nyren O, Adami HO. Esophageal cancer. In: Adami HO, Hunter D, Lagiou P, Mucci LA, editors. Textbook of cancer epidemiology. 3rd ed. New York: Oxford University Press; 2017.

    Google Scholar 

  5. Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, et al. Cancer incidence in five continents: inclusion criteria, highlights from volume X and the global status of cancer registration. Int J Cancer. 2015;137(9):2060–71. doi:10.1002/ijc.29670.

    Article  CAS  PubMed  Google Scholar 

  6. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262.

    Article  PubMed  Google Scholar 

  7. He Y, Wu Y, Song G, Li Y, Liang D, Jin J, et al. Incidence and mortality rate of esophageal cancer has decreased during past 40 years in Hebei Province, China. Chin J Cancer Res. 2015;27(6):562–71. doi:10.3978/j.issn.1000-9604.2015.10.06.

    PubMed  PubMed Central  Google Scholar 

  8. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. doi:10.3322/caac.21338.

    Article  PubMed  Google Scholar 

  9. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomark Prev. 2008;17(11):3062–8. doi:10.1158/1055-9965.epi-08-0558.

    Article  Google Scholar 

  10. Chen X, Winckler B, Lu M, Cheng H, Yuan Z, Yang Y, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS ONE. 2015;10(12):e0143603. doi:10.1371/journal.pone.0143603.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Natl Cancer Inst. 2004;96(5):388–96.

    Article  Google Scholar 

  12. Nasrollahzadeh D, Malekzadeh R, Ploner A, Shakeri R, Sotoudeh M, Fahimi S, et al. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep. 2015;5:8820. doi:10.1038/srep08820.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Nasrollahzadeh D, Ye W, Shakeri R, Sotoudeh M, Merat S, Kamangar F, et al. Contact with ruminants is associated with esophageal squamous cell carcinoma risk. Int J Cancer. 2015;136(6):1468–74. doi:10.1002/ijc.29109.

    Article  CAS  PubMed  Google Scholar 

  14. Edgren G, Adami HO, Weiderpass E, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406–14. doi:10.1136/gutjnl-2012-302412.

    Article  PubMed  Google Scholar 

  15. Ghasemi-Kebria F, Roshandel G, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, et al. Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. Arch Iran Med. 2013;16(6):320–3.

    PubMed  Google Scholar 

  16. Fan YJ, Song X, Li JL, Li XM, Liu B, Wang R, et al. Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. World J Surg. 2008;32(9):1980–8. doi:10.1007/s00268-008-9674-x.

    Article  PubMed  Google Scholar 

  17. Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45(9):884–91. doi:10.1093/jjco/hyv088.

    Article  PubMed  Google Scholar 

  18. Hansson LE, Bergstrom R, Sparen P, Adami HO. The decline in the incidence of stomach cancer in Sweden 1960–1984: a birth cohort phenomenon. Int J Cancer. 1991;47(4):499–503.

    Article  CAS  PubMed  Google Scholar 

  19. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303(17):1723–8. doi:10.1001/jama.2010.496.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Song H, Held M, Sandin S, Rautelin H, Eliasson M, Soderberg S, et al. Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in Northern Sweden between 1990 and 2009. Clin Gastrol Hepatol. 2015;13(9):1592–600. doi:10.1016/j.cgh.2015.04.001.

    Article  Google Scholar 

  21. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242–9. doi:10.1056/nejm199607253350404.

    Article  CAS  PubMed  Google Scholar 

  22. Giovanucci E, Keum N, Wu K, Hunter D. Colorectal cancer. In: Adami HO, Hunter D, Lagiou P, Mucci LA, editors. Textbook of cancer epidemiology. 3rd ed. New York: Oxford University Press; 2017.

    Google Scholar 

  23. Graff R, Möller S, Passarelli M, Witte J, Skytthe A, Adami H, et al. The familial risk and heritability of colorectal cancer in the Nordic Twin Study of Cancer (NorTwinCan) (submitted).

  24. http://www-dep.iarc.fr/NORDCAN/english/frame.asp. Database on the Internet. Accessed 28 June 2016.

  25. Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, et al. Familial risk and heritability of cancer among twins in nordic countries. JAMA. 2016;315(1):68–76. doi:10.1001/jama.2015.17703.

    Article  CAS  PubMed  Google Scholar 

  26. Adami HO, Bergstrom R, Mohner M, Zatonski W, Storm H, Ekbom A, et al. Testicular cancer in nine northern European countries. Int J Cancer. 1994;59(1):33–8.

    Article  CAS  PubMed  Google Scholar 

  27. Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst. 1996;88(11):727–33.

    Article  CAS  PubMed  Google Scholar 

  28. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337(19):1350–8. doi:10.1056/nejm199711063371904.

    Article  CAS  PubMed  Google Scholar 

  29. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31. doi:10.1056/nejm199903183401101.

    Article  CAS  PubMed  Google Scholar 

  30. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet. 1992;340(8826):1015–8.

    Article  CAS  PubMed  Google Scholar 

  31. Ye W, Chang E, Liu Z, Huang G, Zeng Y, Zeng Y, et al. Development of population-based research methods in China (submitted).

  32. Lowy DR, Collins FS. Aiming high—changing the trajectory for cancer. N Engl J Med. 2016;374(20):1901–4. doi:10.1056/NEJMp1600894.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Adami H-O. A paradise for epidemiologists? Lancet. 1996;347(9001):588–9.

    Article  Google Scholar 

  34. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328(7455):1519. doi:10.1136/bmj.38142.554479.AE.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997;350(9084):1047–59.

    Article  Google Scholar 

  36. Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011;365(14):1304–14. doi:10.1056/NEJMoa1013961.

    Article  CAS  PubMed  Google Scholar 

  37. Mucci LA, Adami HO. The plight of the potato: is dietary acrylamide a risk factor for human cancer? J Natl Cancer Inst. 2009;101(9):618–21. doi:10.1093/jnci/djp080.

    Article  CAS  PubMed  Google Scholar 

  38. Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14(5):365–76. doi:10.1038/nrn3475.

    Article  CAS  PubMed  Google Scholar 

  39. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Non-ionizing radiation, part 2: Radiofrequency electromagnetic fields. Lyon: The International Agency for Research on Cancer; 2013.

  40. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2(8):e124. doi:10.1371/journal.pmed.0020124.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst. 2008;100(14):988–95. doi:10.1093/jnci/djn191.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Mayer-Schönberger V, Cukier K. Big Data: a revolution that will transform how we live, work, and think. London: John Murray; 2014.

    Google Scholar 

  43. Pentland S. Social physics: how good ideas spread—the lessons from a new science. New York, NY: Penguin Press; 2014.

    Google Scholar 

  44. Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375(15):1438–47. doi:10.1056/NEJMoa1600249.

    Article  PubMed  Google Scholar 

  45. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203–10. doi:10.1056/NEJMoa1000727.

    Article  CAS  PubMed  Google Scholar 

  46. Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Int Med. 2012;156(7):491–9. doi:10.7326/0003-4819-156-7-201204030-00005.

    Article  PubMed  Google Scholar 

  47. Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ. 2015;. doi:10.1136/bmj.g7773.

    PubMed Central  Google Scholar 

  48. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev. 2006;15(10):1765–77. doi:10.1158/1055-9965.epi-06-0353.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We express our sincere thanks to Ellen Chang, Gustaf Edgren, Anders Ekbom, and Pagona Lagiou for their valuable comments. This work was supported by Karolinska Institutet Distinguished Professor Award to Prof. Hans-Olov Adami (Dnr: 2368/10-221).

Author information

Authors and Affiliations

  1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, P.O.B 281, 171 77, Stockholm, Sweden

    Hans-Olov Adami & Olof Nyrén

  2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Hans-Olov Adami

  3. Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway

    Hans-Olov Adami

Authors
  1. Hans-Olov Adami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olof Nyrén
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Olov Adami.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adami, HO., Nyrén, O. Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol 31, 1161–1171 (2016). https://doi.org/10.1007/s10654-016-0218-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-016-0218-7

Keywords

Search

Navigation